Matthew F. Brown

5.2k citations

38 papers · 1.5k indexed · h-index 20

Molecular Biology
Pulmonary and Respiratory Medicine top 10%
Gastroenterology top 1%
Oncology top 10%
Organic Chemistry top 10%

Co-authors: Daniel F. Harvey Ronald P. Gladue Maria Dêbiec‐Rychter Adam B. Salmon Robert D. Pates James M. Beach Samuel H. Zwillich T. S. Wiedmann
Topics: Gastrointestinal Tumor Research and Treatment (5 papers)Synthetic Organic Chemistry Methods (5 papers)Antibiotic Resistance in Bacteria (4 papers)
Cited by: Gastroenterology Molecular Medicine Oncology
Journals: Journal of the American Chemical Society Journal of Biological Chemistry Nature Communications
Partner nations: United States United Kingdom China

In The Last Decade

Matthew F. Brown

36 papers receiving 1.5k citations

Peers

Countries citing papers authored by Matthew F. Brown

Since Specialization

Citations

This map shows the geographic impact of Matthew F. Brown's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Matthew F. Brown with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Matthew F. Brown more than expected).

Fields of papers citing papers by Matthew F. Brown

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Matthew F. Brown. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Matthew F. Brown. The network helps show where Matthew F. Brown may publish in the future.

Co-authorship network of co-authors of Matthew F. Brown

This figure shows the co-authorship network connecting the top 25 collaborators of Matthew F. Brown. A scholar is included among the top collaborators of Matthew F. Brown based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Matthew F. Brown. Matthew F. Brown is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Delivering on the promise of protein degraders 2023 ·Nature Reviews Drug Discovery ·Matthew N. O’Brien,Suman Luthra,Matthew F. Brown,Derek W. Bartlett	60
2	Snapshots and ensembles of BTK and cIAP1 protein degrader ternary complexes 2020 ·Nature Chemical Biology ·James Schiemer,Reto Horst,Yilin Meng,Justin I. Montgomery,Yingrong Xu,Xidong Feng,Kris A. Borzilleri,Daniel P. Uccello,Carolyn A. Leverett,Stephen Brown,Ye Che,Matthew F. Brown,Matthew M. Hayward,A. Gilbert,Mark C. Noe,Matthew F. Calabrese	83
3	Hydropathy Patterning Complements Charge Patterning to Describe Conformational Preferences of Disordered Proteins 2020 ·The Journal of Physical Chemistry Letters ·Wenwei Zheng,Gregory L. Dignon,Matthew F. Brown,Young C. Kim,Jeetain Mittal	81
4	Process Development for the Synthesis of Monocyclic β-Lactam Core 17 2018 ·Organic Process Research & Development ·Manjinder S. Lall,Yong Tao,Joel T. Arcari,(unknown),Matthew F. Brown,David B. Damon,(unknown),Mark J. Mitton‐Fry,Jeremy T. Starr,(unknown),Jianmin Sun	12
5	Exploiting Radiation-Induced Signaling to Increase the Susceptibility of Resistant Cancer Cells to Targeted Drugs: AKT and mTOR Inhibitors as an Example 2017 ·Molecular Cancer Therapeutics ·Iris Eke,Adeola Y. Makinde,Molykutty J. Aryankalayil,Veit Sandfort,Sanjeewani T. Palayoor,Barbara H. Rath,Lance A. Liotta,Mariaelena Pierobon,Emanuel F. Petricoin,Matthew F. Brown,Jayne M. Stommel,Mansoor M. Ahmed,C. Norman Coleman	26
6	Clearance Prediction of Targeted Covalent Inhibitors by In Vitro-In Vivo Extrapolation of Hepatic and Extrahepatic Clearance Mechanisms 2016 ·Drug Metabolism and Disposition ·Louis Leung,Xin Yang,Timothy J. Strelevitz,Justin I. Montgomery,Matthew F. Brown,Michael Zientek,Christopher Banfield,A. Gilbert,Atli Thorarensen,Martin E. Dowty	25
7	Loss of Caspase-3 sensitizes colon cancer cells to genotoxic stress via RIP1-dependent necrosis 2015 ·Cell Death and Disease ·Matthew F. Brown,Brian J. Leibowitz,(unknown),Kan He,Fangdong Zou,Robert W. Sobol,Donna Beer–Stolz,Lin Zhang,Jian Yu	40
8	Unbiased Compound Screening Identifies Unexpected Drug Sensitivities and Novel Treatment Options for Gastrointestinal Stromal Tumors 2014 ·Cancer Research ·Sergei Boichuk,(unknown),(unknown),Kathleen R. Makielski,Agnieszka Woźniak,Danushka S. Seneviratne,Nina Korzeniewski,Rolando Cuevas,Joshua A. Parry,Matthew F. Brown,James P. Zewe,Takahiro Taguchi,(unknown),Patrick Schöffski,Maria Dêbiec‐Rychter,Anette Duensing	37
9	Siderophore Receptor-Mediated Uptake of Lactivicin Analogues in Gram-Negative Bacteria 2014 ·Journal of Medicinal Chemistry ·Jeremy T. Starr,Matthew F. Brown,Lisa Aschenbrenner,Nicole Caspers,Ye Che,Brian S. Gerstenberger,Michael D. Huband,John D. Knafels,M. Megan Lemmon,Chao Li,Sandra P. McCurdy,Eric B. McElroy,(unknown),Andrew P. Tomaras,Jennifer A. Young,Richard P. Zaniewski,Veerabahu Shanmugasundaram,Seungil Han	46
10	The Multi-Targeted Kinase Inhibitor Sunitinib Induces Apoptosis in Colon Cancer Cells via PUMA 2012 ·PLoS ONE ·Jing Sun,Quanhong Sun,Matthew F. Brown,Crissy Dudgeon,Julie Chandler,Xiang Xu,(unknown),Lin Zhang,Jian Yu	40
11	A medium-throughput compound screen identifies novel treatment options for gastrointestinal stromal tumors (GIST) 2012 ·Sergei Boichuk,(unknown),(unknown),Kathleen R. Makielski,Agnieszka Woźniak,Nina Korzeniewski,Rolando Cuevas,James P. Zewe,Shih–Fan Kuan,(unknown),Matthew F. Brown,Takahiro Taguchi,Patrick Schöffski,Maria Dêbiec‐Rychter,Anette Duensing	1
12	Structure–activity relationships and hepatic safety risks of thiazole agonists of the thrombopoietin receptor 2010 ·Bioorganic & Medicinal Chemistry Letters ·(unknown),(unknown),William H. Brissette,Matthew F. Brown,Jeffrey Casavant,Jonathan L. Doty,James P. Driscoll,Thomas M. Harris,Christopher S. Jones,Sandra P. McCurdy,Eric B. McElroy,Mark J. Mitton‐Fry,Michael J. Munchhof,(unknown),Lawrence A. Reiter,Sharon L. Ripp,Andrei Shavnya,(unknown),(unknown)	7
13	CCR1 Antagonists: What Have We Learned From Clinical Trials 2010 ·Current Topics in Medicinal Chemistry ·Ronald P. Gladue,Matthew F. Brown,Samuel H. Zwillich	65
14	Proapoptotic Activity of Bortezomib in Gastrointestinal Stromal Tumor Cells 2009 ·Cancer Research ·Sebastian Bauer,Joshua A. Parry,Thomas Mühlenberg,Matthew F. Brown,Danushka S. Seneviratne,Payel Chatterjee,Anna Chin,Brian P. Rubin,(unknown),Jonathan A. Fletcher,Stefan Duensing,Anette Duensing	34
15	Process Development of CP-481715, a Novel CCR1 Antagonist 2005 ·Organic Process Research & Development ·Bryan Li,Brian M. Andresen,Matthew F. Brown,(unknown),(unknown),Michel Couturier,Eric L. Dias,Frank J. Urban,V. John Jasys,John C. Kath,William S. Kissel,(unknown),(unknown),Joanna T. Negri,Christopher S. Poss,John L. Tucker,David C. Whritenour,Kathleen S. Zandi	9
16	Potent small molecule CCR1 antagonists 2004 ·Bioorganic & Medicinal Chemistry Letters ·John C. Kath,William H. Brissette,Matthew F. Brown,Maryrose J. Conklyn,(unknown),Peter H. Dorff,Ronald P. Gladue,Brett M. Lillie,Paul D. Lira,(unknown),William H. Martin,Eric B. McElroy,(unknown),Timothy Paradis,Christopher S. Poss,Ingrid A. Stock,Laurie Tylaska,(unknown)	17
17	CP-481,715, a Potent and Selective CCR1 Antagonist with Potential Therapeutic Implications for Inflammatory Diseases 2003 ·Journal of Biological Chemistry ·Ronald P. Gladue,Laurie Tylaska,William H. Brissette,Paul D. Lira,John C. Kath,Christopher S. Poss,Matthew F. Brown,Timothy Paradis,Maryrose J. Conklyn,(unknown),(unknown),Brett M. Lillie,(unknown),(unknown),Eric B. McElroy,William H. Martin,Ingrid A. Stock,Richard M. Shepard,Henry J. Showell,Kuldeep Neote	59
18	N-carbamoyl analogs of zafirlukast: Potent receptor antagonists of leukotriene D4 1998 ·Bioorganic & Medicinal Chemistry Letters ·Matthew F. Brown,Anthony Marfat,(unknown),Robert Chambers,John B. Cheng,David B. Damon,Theodore E. Liston,(unknown),(unknown),(unknown),(unknown),(unknown),J. W. Watson	4
19	Molybdenum carbene complexes: Cyclopropanation of electron-poor olefins 1990 ·Tetrahedron Letters ·Daniel F. Harvey,Matthew F. Brown	44
20	Lipid-protein interactions mediate the photochemical function of rhodopsin 1988 ·Biochemistry ·T. S. Wiedmann,Robert D. Pates,James M. Beach,Adam B. Salmon,Matthew F. Brown	136

About Matthew F. Brown

Matthew F. Brown is a scholar working on Gastroenterology, Molecular Medicine and Oncology, having authored 38 papers that have together received 1.5k indexed citations. Recurring topics across this work include Gastrointestinal Tumor Research and Treatment (5 papers), Synthetic Organic Chemistry Methods (5 papers) and Antibiotic Resistance in Bacteria (4 papers). The work is most often cited by research in Gastroenterology (346 citations), Molecular Medicine (140 citations) and Oncology (302 citations). Matthew F. Brown has collaborated with scholars based in United States, United Kingdom and China. Frequent co-authors include Daniel F. Harvey, Ronald P. Gladue, Maria Dêbiec‐Rychter, Adam B. Salmon, Robert D. Pates, James M. Beach, Samuel H. Zwillich, T. S. Wiedmann, Michel Stul and Bartosz Wasąg. Their work appears in journals such as Journal of the American Chemical Society, Journal of Biological Chemistry and Nature Communications.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact